Literature DB >> 17267315

Immunohistochemical analysis of pro-apoptotic PUMA protein and mutational analysis of PUMA gene in gastric carcinomas.

N J Yoo1, J W Lee, E G Jeong, S H Lee.   

Abstract

BACKGROUND: Mounting evidence indicates that alteration of apoptosis is involved in the mechanisms of cancer development. PUMA, a pro-apoptotic member of Bcl-2 family, mediates p53-dependent and -independent apoptosis. AIM: The aim of this study was to explore whether alteration of PUMA protein expression is a characteristic of human gastric carcinomas. PATIENTS AND METHODS: We analysed expression of PUMA protein in 60 gastric adenocarcinomas by immunohistochemistry. Also, we examined PUMA gene mutation in the same tissues by a single-strand conformation polymorphism.
RESULTS: PUMA protein expression was detected in 44 cases (73%) of the 60 gastric carcinomas, whereas it was not detected in normal gastric mucosal epithelial cells. The mutational analysis revealed no PUMA mutation in the gastric carcinomas.
CONCLUSIONS: Our data suggest that PUMA mutation is not a direct target of inactivation in gastric tumourigenesis. Also, increased expression of PUMA in malignant gastric epithelial cells compared with normal mucosal epithelial cells suggested that PUMA expression may play a role in gastric tumourigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17267315     DOI: 10.1016/j.dld.2006.11.006

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  3 in total

Review 1.  PUMA, a potent killer with or without p53.

Authors:  J Yu; L Zhang
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

2.  Genetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma.

Authors:  K Holmes; B Egan; N Swan; C O'Morain
Journal:  Curr Genomics       Date:  2007-09       Impact factor: 2.236

Review 3.  PUMA, a critical mediator of cell death--one decade on from its discovery.

Authors:  Paweł Hikisz; Zofia M Kiliańska
Journal:  Cell Mol Biol Lett       Date:  2012-09-20       Impact factor: 5.787

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.